Acadia Pharmaceuticals Inc SEC filings ACAD

Acadia Pharmaceuticals Inc has 1,000 filings in SEC EDGAR's recent list, going back to Nov 9, 2010. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Acadia Pharmaceuticals Inc SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
4 Insider transaction Oct 30, 2026 Oct 15, 2026
8-K Current report
Officer or director change
Oct 23, 2026 Oct 23, 2026
8-K Current report
Regulation FD disclosure, Other events
Sep 24, 2026 Sep 24, 2026
8-K Current report
Other events
Sep 11, 2026 Sep 11, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
144 Notice of proposed sale Aug 5, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
4 Insider transaction Jul 31, 2026 Jul 29, 2026
4 Insider transaction Jun 29, 2026 Jun 26, 2026
144 Notice of proposed sale Jun 26, 2026 —
S-8 Employee stock plan registration Jun 10, 2026 —
4 Insider transaction Jun 2, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
4 Insider transaction Jun 1, 2026 May 29, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2026 May 29, 2026
4 Insider transaction May 27, 2026 May 26, 2026
144 Notice of proposed sale May 26, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
4 Insider transaction May 5, 2026 May 1, 2026
4 Insider transaction May 5, 2026 May 1, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
May 1, 2026 Apr 27, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 28, 2026 —
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 24, 2026 May 29, 2026
4 Insider transaction Apr 7, 2026 Apr 5, 2026
4 Insider transaction Apr 7, 2026 Apr 5, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
4 Insider transaction Mar 26, 2026 Mar 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 20, 2026 Mar 3, 2026
3 Initial insider ownership Mar 20, 2026 Mar 3, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
8-K Current report
Officer or director change
Mar 5, 2026 Mar 3, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 26, 2026 —
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2026 Jan 13, 2026
4 Insider transaction Nov 19, 2025 Nov 17, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 12, 2025 Nov 10, 2025
144 Notice of proposed sale Nov 10, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 5, 2025 Nov 5, 2025
8-K Current report
Officer or director change
Nov 3, 2025 Oct 28, 2025
4 Insider transaction Sep 16, 2025 Sep 12, 2025
4 Insider transaction Sep 3, 2025 Sep 2, 2025
4 Insider transaction Aug 19, 2025 Aug 18, 2025
144 Notice of proposed sale Aug 18, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
8-K Current report
Other events
Jun 10, 2025 Jun 9, 2025
4 Insider transaction Jun 5, 2025 Jun 4, 2025
144 Notice of proposed sale Jun 4, 2025 —
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
4 Insider transaction Jun 2, 2025 May 29, 2025
8-K Current report
Shareholder vote results
May 29, 2025 May 29, 2025
EFFECT Filing May 23, 2025 —
CORRESP Letter to the SEC May 21, 2025 —
8-K Current report
Material agreement, Other events
May 20, 2025 May 15, 2025
4 Insider transaction May 19, 2025 May 16, 2025
4 Insider transaction May 19, 2025 May 16, 2025
144 Notice of proposed sale May 16, 2025 —
144 Notice of proposed sale May 16, 2025 —
UPLOAD Letter from the SEC May 14, 2025 —
S-3 Shelf registration May 9, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
4 Insider transaction May 2, 2025 May 1, 2025
4 Insider transaction May 2, 2025 May 1, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 25, 2025 May 29, 2025
8-K Current report
Bylaw or fiscal year change
Apr 16, 2025 Apr 15, 2025
4 Insider transaction Apr 8, 2025 Apr 5, 2025
4 Insider transaction Apr 8, 2025 Apr 5, 2025
4 Insider transaction Mar 26, 2025 Mar 24, 2025
4 Insider transaction Mar 26, 2025 Mar 24, 2025
4 Insider transaction Mar 26, 2025 Mar 24, 2025
4 Insider transaction Mar 26, 2025 Mar 24, 2025
4 Insider transaction Mar 26, 2025 Mar 24, 2025
4 Insider transaction Mar 6, 2025 Mar 5, 2025
144 Notice of proposed sale Mar 6, 2025 —
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
4 Insider transaction Feb 25, 2025 Feb 23, 2025
4 Insider transaction Feb 25, 2025 Feb 23, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
8-K Current report
Acquisition or sale of assets
Dec 11, 2024 Dec 11, 2024
4 Insider transaction Dec 10, 2024 Dec 9, 2024
3 Initial insider ownership Dec 10, 2024 Dec 9, 2024
8-K Current report
Officer or director change
Nov 20, 2024 Nov 18, 2024
4 Insider transaction Nov 19, 2024 Nov 17, 2024
4 Insider transaction Nov 19, 2024 Nov 17, 2024
4 Insider transaction Nov 19, 2024 Nov 17, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
4 Insider transaction Oct 15, 2024 Oct 12, 2024
4 Insider transaction Sep 25, 2024 Sep 23, 2024
3 Initial insider ownership Sep 25, 2024 Sep 23, 2024
S-8 Employee stock plan registration Sep 23, 2024 —
8-K Current report
Officer or director change
Sep 23, 2024 Sep 17, 2024
4 Insider transaction Aug 20, 2024 Aug 16, 2024
4 Insider transaction Aug 20, 2024 Aug 16, 2024
4 Insider transaction Aug 20, 2024 Aug 16, 2024
S-8 POS Filing Aug 20, 2024 —
S-8 POS Filing Aug 20, 2024 —
S-8 POS Filing Aug 20, 2024 —
S-8 POS Filing Aug 20, 2024 —
S-8 POS Filing Aug 20, 2024 —
S-8 POS Filing Aug 20, 2024 —
S-8 POS Filing Aug 20, 2024 —
S-8 POS Filing Aug 20, 2024 —
S-8 POS Filing Aug 20, 2024 —
4 Insider transaction Aug 13, 2024 Aug 12, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
4 Insider transaction Jun 11, 2024 Jun 8, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
4 Insider transaction May 31, 2024 May 29, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2024 May 29, 2024
S-8 POS Filing May 29, 2024 —
S-8 POS Filing May 29, 2024 —
S-8 POS Filing May 29, 2024 —
S-8 POS Filing May 29, 2024 —
S-8 POS Filing May 29, 2024 —
S-8 POS Filing May 29, 2024 —
S-8 POS Filing May 29, 2024 —
S-8 POS Filing May 29, 2024 —
S-8 POS Filing May 29, 2024 —
S-8 Employee stock plan registration May 29, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
4 Insider transaction May 3, 2024 May 1, 2024
4 Insider transaction May 3, 2024 May 1, 2024
4 Insider transaction May 3, 2024 May 1, 2024
4 Insider transaction May 3, 2024 May 1, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
DEF 14A Proxy statement Apr 26, 2024 May 29, 2024
3 Initial insider ownership Apr 15, 2024 Apr 4, 2024
4 Insider transaction Apr 9, 2024 Apr 5, 2024
4 Insider transaction Apr 9, 2024 Apr 5, 2024
4 Insider transaction Apr 9, 2024 Apr 5, 2024
4 Insider transaction Apr 9, 2024 Apr 5, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
4 Insider transaction Mar 27, 2024 Mar 25, 2024
8-K Current report
Other events
Mar 11, 2024 Mar 11, 2024
10-K Annual report Feb 28, 2024 Dec 31, 2023
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
8-K Current report
Results of operations
Feb 27, 2024 Feb 27, 2024
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
4 Insider transaction Feb 8, 2024 Feb 6, 2024
3 Initial insider ownership Feb 8, 2024 Feb 6, 2024
8-K Current report
Officer or director change
Jan 31, 2024 Jan 30, 2024
SC 13G/A Amended ownership over 5% (passive) Jan 26, 2024 —
4 Insider transaction Jan 9, 2024 Jan 6, 2024
4 Insider transaction Jan 9, 2024 Jan 6, 2024
4 Insider transaction Jan 9, 2024 Jan 6, 2024
4 Insider transaction Dec 15, 2023 Dec 15, 2023
144 Notice of proposed sale Dec 15, 2023 —
4 Insider transaction Nov 28, 2023 Nov 24, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023
4 Insider transaction Nov 21, 2023 Nov 17, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ACAD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1070494

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.